bf/NASDAQ:MRNA_icon.jpeg

NASDAQ:MRNA

Moderna Inc.

  • Stock

USD

Last Close

132.68

17/05 20:00

Market Cap

38.82B

Beta: 1.70

Volume Today

2.70M

Avg: 3.57M

PE Ratio

−10.50

PFCF: −13.71

Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
-86.50M
-
-538.59M
522.69%
-428.83M
20.38%
743.76M
273.44%
1.20B
60.67%
575.50M
51.84%
average payables
24.44M
-
25.97M
6.25%
19.15M
26.25%
12.72M
33.55%
160.18M
1,158.83%
394.50M
146.29%
503.50M
27.63%
average receivables
17.30M
-
23.62M
36.50%
23.44M
0.76%
713.41M
2,943.57%
2.35B
229.86%
2.34B
0.54%
1.14B
51.36%
book value per share
2.24
-
1.66
25.72%
18.87
1,034.40%
3.55
81.19%
6.72
89.41%
35.10
422.10%
48.54
38.28%
36.27
25.28%
capex per share
-0.09
-
-0.16
76.20%
-1.30
739.49%
-0.10
92.69%
-0.18
85.70%
-0.70
298.08%
-1.02
44.06%
-1.85
82.30%
capex to depreciation
-2.19
-
-2.84
29.68%
-4.25
49.60%
-1.02
76.09%
-2.16
112.18%
-1.22
43.28%
-1.15
6.10%
-1.14
0.95%
capex to operating cash flow
-0.50
-
0.18
135.47%
0.32
81.44%
0.07
78.49%
-0.03
148.40%
-0.02
37.34%
-0.08
285.13%
0.23
382.36%
capex to revenue
-0.33
-
-0.33
1.09%
-0.86
161.61%
-0.66
23.91%
-0.25
62.59%
-0.02
93.48%
-0.02
29.68%
-0.10
397.19%
cash per share
2.81
-
2.01
28.55%
18.76
832.83%
3.33
82.23%
12.09
262.91%
26.62
120.10%
25.13
5.58%
7.61
69.72%
days of inventory on hand
5.03K
-
2.14K
-
200.98
90.61%
63.96
68.18%
15.71
75.44%
days payables outstanding
-907.27
-
844.70
-
42.12
95.01%
32.82
22.08%
40.44
23.23%
days sales outstanding
64.53
-
34.35
46.77%
91.12
165.24%
123.83
35.91%
1.88K
1,414.66%
67.83
96.38%
26.24
61.31%
47.54
81.17%
debt to assets
0.03
-
0.08
207.63%
0.06
29.62%
0.13
119.36%
0.09
26.69%
0.04
59.75%
0.05
24.98%
0.07
49.81%
debt to equity
0.04
-
0.14
216.94%
0.07
47.97%
0.17
131.45%
0.26
55.22%
0.06
75.50%
0.06
3.10%
0.09
47.35%
dividend yield
0.00
-
0.00
584.95%
earnings yield
-0.03
-
-0.04
18.36%
-0.31
748.84%
-0.08
74.44%
-0.02
76.36%
0.12
735.16%
0.12
0.89%
-0.12
205.02%
enterprise value
6.96B
-
6.87B
1.17%
613.74M
91.07%
6.37B
938.04%
37.39B
486.84%
96.42B
157.91%
68.77B
28.68%
36.30B
47.21%
enterprise value over ebitda
-33.34
-
-27.63
17.12%
-1.49
94.62%
-11.67
686.09%
-48.99
319.64%
7.25
114.80%
7.04
2.92%
-8.56
221.64%
ev to operating cash flow
104.24
-
-20.74
119.90%
-1.85
91.06%
-13.88
648.31%
18.44
232.88%
7.08
61.62%
13.81
95.01%
-11.64
184.33%
ev to sales
68.51
-
38.84
43.30%
5.01
87.10%
132.63
2,547.44%
136.20
2.70%
5.44
96.01%
3.57
34.34%
5.30
48.49%
free cash flow per share
0.09
-
-1.04
1,260.72%
-5.38
419.12%
-1.48
72.47%
5.14
447.05%
33.09
543.42%
11.63
64.86%
-10.01
186.12%
free cash flow yield
0.00
-
-0.06
1,260.72%
-0.35
532.33%
-0.08
78.51%
0.05
164.98%
0.13
164.66%
0.06
50.32%
-0.10
255.54%
graham net net
1.32
-
0.82
37.67%
12.65
1,437.46%
0.75
94.06%
2.40
219.31%
8.43
251.45%
11.88
40.99%
-2.34
119.72%
graham number
5.38
-
5.05
6.24%
44.87
789.12%
11.14
75.18%
17.22
54.65%
154.63
797.89%
152.24
1.55%
100.35
34.09%
income quality
-0.31
-
1.30
519.66%
0.86
33.61%
0.89
3.83%
-2.71
403.87%
1.12
141.14%
0.60
46.63%
0.66
11.04%
intangibles to total assets
0
-
0
0
0
0
-0.06
Infinity%
0
100%
0
interest coverage
-82.53
-
-77.19
6.47%
738.67
1,056.89%
324.83
56.03%
interest debt per share
0.10
-
0.24
135.41%
1.39
490.23%
0.62
55.02%
1.80
188.75%
2.32
28.57%
3.12
34.59%
3.35
7.51%
inventory turnover
0.07
-
0.17
-
1.82
965.14%
5.71
214.25%
23.23
307.09%
invested capital
0.04
-
0.14
216.94%
0.07
47.97%
0.17
131.45%
0.26
55.22%
0.06
75.50%
0.06
3.10%
0.09
47.35%
market cap
6.99B
-
6.99B
0%
1.24B
82.29%
6.47B
422.71%
39.80B
514.78%
102.35B
157.15%
70.77B
30.86%
37.99B
46.32%
net current asset value
511.84M
-
324.03M
36.69%
1.13B
249.07%
848.38M
25.00%
1.52B
79.46%
7.05B
362.79%
6.70B
4.97%
5.75B
14.08%
net debt to ebitda
0.18
-
0.48
165.93%
1.51
215.70%
0.19
87.46%
3.17
1,569.43%
-0.45
114.09%
-0.21
53.99%
0.40
294.11%
net income per share
-0.58
-
-0.68
18.36%
-4.74
596.87%
-1.55
67.26%
-1.96
26.26%
30.28
1,644.16%
21.22
29.90%
-12.34
158.14%
operating cash flow per share
0.18
-
-0.88
596.72%
-4.08
362.68%
-1.39
66.01%
5.32
483.68%
33.80
535.26%
12.64
62.59%
-8.16
164.56%
payables turnover
-0.40
-
0.43
-
8.67
1,905.43%
11.12
28.34%
9.03
18.85%
receivables turnover
5.66
-
10.63
87.85%
4.01
62.30%
2.95
26.42%
0.19
93.40%
5.38
2,665.18%
13.91
158.47%
7.68
44.80%
research and ddevelopement to revenue
2.71
-
2.32
14.28%
3.71
59.81%
10.33
178.76%
4.99
51.68%
0.11
97.75%
0.17
52.38%
0.71
313.62%
return on tangible assets
-0.15
-
-0.24
54.67%
-0.20
16.91%
-0.32
64.94%
-0.10
68.51%
0.47
557.94%
0.32
30.65%
-0.26
179.11%
revenue per share
0.27
-
0.47
74.30%
1.51
220.89%
0.15
90.39%
0.72
396.44%
44.01
6,008.70%
48.89
11.09%
17.93
63.33%
roe
-0.26
-
-0.41
59.36%
-0.25
38.57%
-0.44
74.03%
-0.29
33.34%
0.86
395.76%
0.44
49.31%
-0.34
177.81%
roic
-0.25
-
-0.37
46.44%
-0.25
33.16%
-0.36
46.54%
-0.22
38.54%
0.76
443.92%
0.39
49.53%
-0.31
180.36%
sales general and administrative to revenue
0.57
-
0.37
35.36%
0.77
110.36%
2.28
196.63%
shareholders equity per share
2.24
-
1.66
25.72%
18.87
1,034.40%
3.55
81.19%
6.72
89.41%
35.10
422.10%
48.54
38.28%
36.27
25.28%
stock based compensation to revenue
0.39
-
0.23
41.61%
0.59
161.70%
1.69
185.12%
0.34
79.93%
0.01
97.64%
0.01
46.54%
0.04
279.62%
tangible asset value
841.85M
-
625.30M
25.72%
1.53B
144.72%
1.17B
23.23%
2.56B
118.02%
15.64B
510.77%
19.12B
22.24%
13.85B
27.55%
tangible book value per share
2.24
-
1.66
25.72%
18.87
1,034.40%
3.55
81.19%
6.72
89.41%
35.10
422.10%
48.54
38.28%
36.27
25.28%
working capital
924.35M
-
591.76M
35.98%
1.34B
126.48%
1.12B
16.44%
1.91B
70.47%
8.44B
342.20%
8.51B
0.78%
7.31B
14.08%

All numbers in USD (except ratios and percentages)